FDA “Critical Path” Leads To Arizona; Rx Development Institute Being Formed
Executive Summary
The Institute for Global Pharmaceutical Development expects to be operational in early 2005 with University of Arizona VP-Health Sciences Raymond Woosley, MD/PhD, as its head
You may also be interested in...
Critical Path Institute’s New Business Model: An Interview With CEO Compton
After six months on the job, Carolyn Compton, the institute’s new chief executive, has overhauled the funding rules to allow fees from big pharma to cover overhead as government funding dries up. Successor to founder Raymond Woosley, who retired last year, Compton shares her vision for securing the institute’s finances for the future amid tough economic times.
Biomarker Working Group To Explore Development Of Guidance
An FDA working group will be formed by year-end to consider the development of a guidance on biomarkers
Biomarker Working Group To Explore Development Of Guidance
An FDA working group will be formed by year-end to consider the development of a guidance on biomarkers